Listing of Kubota Pharmaceutical Holdings Co., Ltd. and Forecast for Fiscal Year End 2016
TOKYO--(BUSINESS WIRE)--Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo: 4596) (the “Company”) hereby gives notice that the merger agreement regarding its proposed redomicile transaction became effective on December 1, 2016 Japan Time. On December 6, 2016 Japan Time, the Company has been listed on the Mothers market of the Tokyo Stock Exchange, Inc. (“TSE”). The Company has also announced earnings and dividend forecasts for the fiscal year end 2016 as follows. 1. Overview of Kubota Pharmaceutic